How to Write a Product Development Brief for Your OEM Manufacturer
Most development delays in health, beauty and supplement manufacturing are not caused by slow factories. They are caused by instructions that were never written down clearly enough to be followed. The product development brief is the document that fixes that — and it is the one document many first-time brand owners never actually produce.
What is a product development brief, and why does it matter?
Quick answer: A product development brief is a written document that tells an OEM/ODM manufacturer exactly what a brand owner wants made — the product concept, target user, format, key ingredients, claims, packaging, budget, volume and timeline — in enough detail that a formulator can act on it without guessing. It matters because every unwritten assumption becomes a revision, and every revision adds weeks and cost to development. A brief does not need to be long; it needs to be specific. The practical starting point is to write down the target retail price and the intended market before anything else, because those two figures constrain every other decision.
Key takeaways
- A brief is a decision document, not a wish list. Its value comes from what it rules out, not only what it asks for.
- Retail price, market of sale and order quantity should appear on page one — they determine what is technically possible.
- Vague descriptors ("natural", "premium", "fast-absorbing") are the single largest source of sample rejections, because the brand owner and the chemist interpret them differently.
- A brief should separate must-have requirements from nice-to-have preferences, so the factory knows where it may substitute.
- Regulatory market must be stated up front. A formula acceptable in one jurisdiction may be non-compliant in another.
- Briefs are living documents. The version that starts development is rarely the version that goes to production — but every change should be recorded.
Who this article is for
This guide is written for brand owners, marketers and entrepreneurs who are about to approach a contract manufacturer for the first time, and for existing brands whose development cycles keep stretching. It assumes the reader has a product idea but has not yet formalised it. Those still deciding between an off-the-shelf and a bespoke formula may find the comparison in private label versus custom formulation a more useful starting point, and those at the earlier concept stage can begin with the broader idea-to-shelf overview.
Why does a vague brief cost more than a strict one?
A vague brief transfers decision-making from the brand owner to the factory, and factories make those decisions based on what is easiest to manufacture, not what the brand intended. This is rarely bad faith. A development chemist receiving a request for "a light, natural-feeling moisturiser at a good price" has to choose an emulsifier system, a texture, a preservative approach and a fill weight with no guidance. If the resulting sample does not match the picture in the brand owner's head, the cycle restarts — and in most contract manufacturing arrangements each revision round adds two to six weeks.
The cost is compounding rather than linear. Each round consumes bench time, raw material samples and internal review, and it also pushes back every downstream activity that depends on a locked formula: stability testing, packaging tooling, artwork, registration and production scheduling. A brand that loses three revision rounds early has usually lost a full quarter by the time it reaches the shelf, which is why development timelines slip far more often than production timelines do. Readers who want the full sequence will find it mapped in the realistic launch timeline guide.
What belongs in a product development brief?
A workable brief covers eight areas, and it can be done in two to three pages. The table below sets out what each section should contain and the question it is really answering for the factory.
| Section | What to include | Question it answers |
|---|---|---|
| 1. Commercial frame | Target retail price, target ex-factory cost, first order quantity, market(s) of sale | What can we afford to put in it? |
| 2. Product definition | Category, dosage or delivery format, fill size, single or multi-SKU range | What are we actually making? |
| 3. Target user | Age band, concern, usage occasion, climate of use, sensitivity considerations | Who has to like this? |
| 4. Performance and sensory | Texture, colour, fragrance direction, absorption, taste and mouthfeel, benchmark products | How should it feel to use? |
| 5. Ingredient position | Hero actives and desired levels, mandatory inclusions, exclusions, certification needs (Halal, vegan, cruelty-free) | What must and must not be in it? |
| 6. Claims intent | Claims the brand intends to make on pack and in marketing | What evidence will we need? |
| 7. Packaging | Primary pack type, material preference, closure, secondary pack, decoration method | What does it ship in? |
| 8. Timeline and approvals | Target launch date, named decision-maker, sample review turnaround commitment | Who decides, and by when? |
Section eight is the one most often omitted and the one that most often causes drift. If a brief does not name a single decision-maker and a review turnaround, samples sit unopened while internal opinion is gathered — and the delay is then attributed to the factory.
How specific does each requirement need to be?
A requirement is specific enough when a chemist who has never met the brand owner could act on it without asking a follow-up question. The most reliable test is whether the statement can be measured, benchmarked or checked against a document. The contrast below uses common phrasing seen in real briefs.
| Vague phrasing | Actionable phrasing |
|---|---|
| "Natural and safe" | "No synthetic fragrance; preservative system acceptable; target 90% plant-derived content by the supplier's own calculation method" |
| "Premium texture" | "Lightweight gel-cream, absorbs within 30 seconds, no white cast, benchmark: [named reference product]" |
| "High-strength vitamin C" | "Sodium ascorbyl phosphate at 3%, or an alternative derivative with comparable stability at the same declared level" |
| "Nice bottle, good quality" | "30 ml airless pump, PP outer, matte finish, silkscreen one colour, stock component preferred over custom tooling" |
| "Competitive price" | "Target ex-factory cost RM 12.00–14.00 per unit at 3,000 units, packaging included" |
The right-hand column does not require technical training to write. It requires the brand owner to make decisions before the factory does. Where a decision genuinely cannot be made yet, the brief should say so explicitly — "fragrance direction to be confirmed after first sample" is far more useful than silence, because it tells the formulator to hold that variable open.
What happens to a brief once it reaches the factory?
Inside a contract manufacturer, the brief is translated into an internal development request that circulates across several functions, and each function reads it for different information. Research and development reads sections four and five to select a base formula and actives. Regulatory affairs reads sections one, five and six to check whether the intended claims and ingredients are permitted in the stated market. Purchasing reads sections one and five to check raw material availability against the cost target. Packaging development reads section seven against tooling lead times and minimum component quantities.
This is why a gap in one section stalls more than one department. A brief that omits the market of sale, for example, prevents regulatory sign-off entirely, because ingredient permissibility and labelling requirements are jurisdiction-specific. In Malaysia, cosmetic products are notified with the National Pharmaceutical Regulatory Agency (NPRA) under the ASEAN Cosmetic Directive framework, while health supplements follow a separate product registration route — and the two pathways impose different documentation demands on the same brand. The practical implications for compliance are covered in more depth in the guide to cosmetic compliance.
Claims intent deserves particular attention. A claim is not a marketing decision that can be added later; it is a technical requirement that may oblige the manufacturer to select specific actives at specific levels, or to commission testing that adds months. Brand owners who write their intended claims into the brief at the start usually discover early which ones are affordable — a far cheaper discovery than making it after artwork is printed. The boundaries are examined in what brands can legally say.
Which parts of a brief should deliberately stay flexible?
A brief that specifies everything is as costly as one that specifies nothing, because it removes the manufacturer's ability to substitute where substitution would save money or time. The useful discipline is to mark each requirement as either a must-have or a preference.
Requirements that are usually worth holding firm include the market of sale, any certification the brand has committed to, declared active levels that support a claim, and the fill size once artwork has been designed around it. Requirements that are usually worth leaving flexible include the specific supplier of a common raw material, the exact shade or fragrance within an agreed direction, the emulsifier or excipient system where performance is equivalent, and the packaging component supplier where a stock alternative meets the same specification.
Flexibility on components in particular has a direct commercial effect. Custom tooling carries both a mould cost and a high minimum order quantity, and a brand that insists on a bespoke bottle at first launch often finds the packaging decision, rather than the formula, has set its minimum order quantity and its unit cost. Stock components with custom decoration achieve much of the visual effect at a fraction of the commitment; the trade-offs are set out in the packaging guide.
What are the most common briefing mistakes?
Five patterns recur often enough to be treated as predictable rather than unlucky.
First, benchmarking a product without stating what is being benchmarked. Naming a reference product is genuinely useful, but a brief should say whether the benchmark applies to texture, performance, ingredient story or price position. A factory asked to "match" a well-known product at a fraction of its cost is being given two contradictory instructions.
Second, writing the claim before checking the evidence burden. Claims such as clinically tested, dermatologically tested, or any statement implying a physiological effect carry substantiation requirements that must be budgeted at the briefing stage.
Third, omitting shelf-life expectations. A required shelf life determines the preservative system, packaging barrier properties and the stability testing programme — and testing runs on calendar time that cannot be compressed.
Fourth, treating the brief as a one-way document. A manufacturer's feedback on a brief is itself valuable information: an objection usually signals a cost, regulatory or technical constraint the brand had not seen. Briefs that are issued and never revised tend to be briefs whose warnings were ignored.
Fifth, briefing before agreeing commercial terms. Formula ownership, confidentiality, exclusivity and what happens to a developed formula if the relationship ends are all easier to settle before development work begins than after. These points are examined in the guide to contract manufacturing agreements, and any brand intending to protect a name should also check availability with MyIPO before committing to artwork.
A practical one-page brief checklist
Before sending a brief to any manufacturer, a brand owner should be able to answer each of the following in a single line. If a line cannot be completed, it should be marked "to be confirmed" rather than left blank.
- Target retail price and target ex-factory cost per unit
- First order quantity, and the realistic reorder quantity
- Market(s) where the product will be sold and registered
- Product format and fill size
- Target user and the single problem the product solves
- Hero ingredients, with levels where a claim depends on them
- Absolute exclusions, including allergens and certification constraints
- Sensory direction with at least one named benchmark
- Intended on-pack claims
- Required shelf life
- Packaging type, decoration method, and whether stock components are acceptable
- Certification required at launch versus later
- Target launch date and the named person who approves samples
A brief containing thirteen honest lines — including several marked "to be confirmed" — is more useful to a manufacturer than a polished ten-page deck that avoids every number. Choosing the right manufacturing partner to receive it is a separate exercise, covered in eight questions to ask before signing.
Frequently asked questions
Do I need a product brief if I am just doing private label?
Yes, though a much shorter one. For a private label product the formula is already fixed, so the brief's job shifts to the decisions that remain open: fill size, packaging, decoration, market of sale, claims and order quantity. A one-page version covering those points still prevents the most common private label problems, which are packaging and labelling mismatches rather than formulation disputes.
Should I share my target cost with the manufacturer?
In most cases yes. Withholding the budget does not produce a better price; it produces a sample that may be unaffordable, followed by a reformulation round to bring the cost down. Stating a target cost range allows the formulator to select raw materials that fit from the outset. Brand owners concerned about being quoted to the ceiling of their budget can state a range and ask for the cost breakdown by formula, packaging and processing.
Can a manufacturer write the brief for me?
A manufacturer can help structure it, and many will supply a template. What a manufacturer cannot supply is the commercial judgement behind it — the price position, the target customer and the claims the brand is willing to defend. If the factory writes those sections, the resulting product reflects the factory's assumptions about the market, and accountability for the outcome becomes unclear.
How detailed should the brief be for a first-time brand with no technical background?
Detail is not the same as technical vocabulary. A non-technical founder can write an entirely usable brief in plain language by describing observable outcomes — how the product should feel, how long it should take to absorb, what it must not contain, what it must cost — and naming benchmark products rather than specifying chemistry. The technical translation is the manufacturer's job; the decisions are not.
How often should a brief be updated during development?
It should be updated whenever a decision changes, and the revision should carry a date and a version number. In practice most projects go through three to five versions between first enquiry and production. The value of versioning becomes clear at handover, when a new team member, a second factory or a regulatory consultant needs to understand why a particular ingredient or component was chosen.
Is a brief the same as a specification sheet?
No, and conflating them causes confusion. A brief states what the brand wants and why; a specification sheet records what the approved product actually is, including the finalised formula reference, physical and microbiological parameters, packaging components and acceptance criteria. The brief comes first and is aspirational; the specification is produced at approval and becomes the quality reference for every future batch.
Sources and further reading
- National Pharmaceutical Regulatory Agency (NPRA), Malaysia — cosmetic notification and product registration requirements.
- ISO 22716: Cosmetics — Good Manufacturing Practices — the GMP reference commonly applied by cosmetic contract manufacturers.
- Intellectual Property Corporation of Malaysia (MyIPO) — trademark search and registration.
Limitations
This article describes general briefing practice observed across health, beauty and supplement contract manufacturing, primarily in a Malaysian and ASEAN context. Individual manufacturers use different intake formats, and requirements vary by product category, claim type and market of registration. Cost figures used in the examples are illustrative only and should not be treated as current market rates. Regulatory pathways change; brand owners should confirm current requirements with the relevant authority or a qualified regulatory consultant before relying on any statement here for a submission.
Disclosure: Creaton Poh is the pen name of Poh Tze Kheng, founder of the ORIZI Group, a Malaysian OEM/ODM manufacturer. This article is educational and independent, and is not promotional.
Written by Creaton Poh
Industry Researcher • Author • Vlogger • Manufacturing Strategist
Turning ideas into products. Turning experience into knowledge.
Connect with Poh Tze Kheng on LinkedIn.
Comments
Post a Comment